Form 4: Surrozen COO Charles Williams Increases Equity Stake

Chief Operating Officer Charles Williams acquired 1,666 shares of Surrozen, Inc. common stock through the company's Employee Stock Purchase Plan.

Summary

• Charles O. Williams, Chief Operating Officer of Surrozen, Inc., acquired 1,666 shares of common stock.
• The transaction occurred on June 15, 2026, at a price of $8.11 per share.
• The acquisition was made via the Surrozen, Inc. 2021 Employee Stock Purchase Plan.
• Following this transaction, the reporting person's total beneficial ownership is 18,237 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, small-scale purchase under an existing employee stock plan rather than a significant open-market acquisition.

Positives

• Internal alignment as the COO increases his equity stake in the company.
• The purchase was executed through a standard employee benefit plan, indicating participation in company-sponsored equity programs.

Negatives

• None identified.

Risks

• General market risks associated with equity ownership in a biotechnology company.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that routine insider purchases via Employee Stock Purchase Plans are common in the biotech sector and generally reflect standard participation in compensation programs rather than a specific signal regarding near-term clinical or financial performance.

Comparison to Industry Standards

• The transaction is consistent with standard executive compensation and equity participation practices observed across the biotechnology industry.

Stakeholder Impact

• Minor increase in insider alignment with shareholder interests.

Next Steps

• None specified.

Key Dates

Keywords

Surrozen, SRZN, Insider Trading, Form 4, Biotech, Equity Purchase